Published in Blood on May 15, 1990
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06
Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J (1993) 1.61
Inhibition of transferrin iron release increases in vitro drug carrier efficacy. J Control Release (2006) 1.54
Streptococcus mutans extracellular DNA is upregulated during growth in biofilms, actively released via membrane vesicles, and influenced by components of the protein secretion machinery. J Bacteriol (2014) 1.10
The antitumor activity of the fungicide ciclopirox. Int J Cancer (2010) 1.02
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery. Cancer Res (2010) 0.95
Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins. J Control Release (2008) 0.95
Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes. J Clin Invest (1994) 0.89
Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research. Nutrients (2013) 0.86
Progressive renal toxicity due to ifosfamide. Arch Dis Child (1991) 0.85
Iron: a target for the management of Kaposi's sarcoma? BMC Cancer (2004) 0.85
Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin. J Inorg Biochem (2011) 0.84
Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer. Ann Biomed Eng (2011) 0.83
Phosphorylation regulates the ferritoid-ferritin interaction and nuclear transport. J Cell Biochem (2009) 0.78
Serum transferrin receptors in rheumatoid arthritis. Ann Rheum Dis (1994) 0.78
Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles. Biomacromolecules (2013) 0.76
Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations. Transl Oncogenomics (2014) 0.76
Mathematical Modeling of Mutant Transferrin-CRM107 Molecular Conjugates for Cancer Therapy. J Theor Biol (2017) 0.75
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas. PLoS One (2016) 0.75
Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients? Indian J Nephrol (2009) 0.75
Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. World J Stem Cells (2013) 0.75
N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. J Med Chem (2005) 0.75
Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin. Bosn J Basic Med Sci (2016) 0.75
Accelerated neuronal differentiation toward motor neuron lineage from human embryonic stem cell line (H9). Tissue Eng Part C Methods (2014) 0.75
Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma. Oncogene (2017) 0.75
The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta (1996) 6.15
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature (1991) 3.10
On ferritin heterogeneity. Further evidence for heteropolymers. J Biol Chem (1978) 2.64
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem (2000) 1.88
Identification of the ferroxidase centre in ferritin. FEBS Lett (1989) 1.78
Structure, function, and evolution of ferritins. J Inorg Biochem (1992) 1.77
Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood (2000) 1.71
Structural heterogeneity and subunit composition of horse ferritins. Biochemistry (1982) 1.71
A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem (2001) 1.69
Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem (2000) 1.66
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J (1992) 1.58
Congenital choledochal cyst: video-guided laparoscopic treatment. Surg Laparosc Endosc (1995) 1.54
Human isoferritins in normal and disease states. Semin Hematol (1977) 1.50
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia (2006) 1.45
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol (1994) 1.43
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem (1993) 1.43
Reaction paths of iron oxidation and hydrolysis in horse spleen and recombinant human ferritins. Biochemistry (1998) 1.42
A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem (1995) 1.40
Expression and structural and functional properties of human ferritin L-chain from Escherichia coli. Biochemistry (1989) 1.34
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol (1991) 1.32
Structural and immunological relationships of isoferritins in normal and malignant cells. Cancer Res (1976) 1.31
Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. J Biol Chem (1992) 1.30
Evidence that residues exposed on the three-fold channels have active roles in the mechanism of ferritin iron incorporation. Biochem J (1996) 1.26
Influence of site-directed modifications on the formation of iron cores in ferritin. J Mol Biol (1991) 1.25
Ferroxidase kinetics of human liver apoferritin, recombinant H-chain apoferritin, and site-directed mutants. Biochemistry (1993) 1.22
Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br J Haematol (1998) 1.20
Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol (1995) 1.19
Mutational analysis of the channel and loop sequences of human ferritin H-chain. Biochem J (1989) 1.19
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15
Multiple subunits in human ferritins: evidence for hybrid molecules. Biochem Biophys Res Commun (1975) 1.15
Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells. Biochem Biophys Res Commun (1985) 1.14
The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis. Haematologica (1999) 1.14
Functional and immunological analysis of recombinant mouse H- and L-ferritins from Escherichia coli. Protein Expr Purif (2000) 1.13
Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood (1991) 1.11
Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology (2001) 1.09
Immunologic differences in human isoferritins: implications for immunologic quantitation of serum ferritin. Blood (1977) 1.08
Multifunctional nanoparticles for dual imaging. Anal Chem (2011) 1.07
Identification of the EPR-active iron-nitrosyl complexes in mammalian ferritins. Biochemistry (1994) 1.06
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim Biophys Acta (1986) 1.06
Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut (2002) 1.04
Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood (1998) 1.04
Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci U S A (1991) 1.04
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol (1999) 1.04
Characterization of serum ferritin in iron overload: possible identity to natural apoferritin. Br J Haematol (1977) 1.02
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
Iron detoxifying activity of ferritin. Effects of H and L human apoferritins on lipid peroxidation in vitro. FEBS Lett (1990) 0.99
Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres. Biochem J (1996) 0.99
Characterization of human ferritin H chain synthetized in Escherichia coli. Gene (1987) 0.95
Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli. Biochem J (1994) 0.95
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. Gastroenterology (1989) 0.95
Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem (1992) 0.94
Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girls. Eur J Clin Nutr (2003) 0.93
Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol (2000) 0.93
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
Characterization of the ferritin receptors of human T lymphoid (MOLT-4) cells. J Lab Clin Med (1992) 0.92
Biochemical characterization and crystal structure of a recombinant hen avidin and its acidic mutant expressed in Escherichia coli. Eur J Biochem (1998) 0.92
Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. Biophys J (2000) 0.92
Construction of a ferroxidase center in human ferritin L-chain. J Biol Chem (1994) 0.91
Tyrosyl radical formation during the oxidative deposition of iron in human apoferritin. Biochemistry (1995) 0.91
Production of a soluble and functional recombinant streptavidin in Escherichia coli. Protein Expr Purif (1998) 0.91
Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production. Int J Cancer (2001) 0.91
Is hydrogen peroxide produced during iron(II) oxidation in mammalian apoferritins? Biochemistry (2001) 0.89
Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scand J Haematol (1983) 0.89
[Definition of obesity in childhood: criteria and limits]. Minerva Pediatr (2003) 0.89
A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model. J Control Release (2009) 0.88
Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells. Biochem Biophys Res Commun (1986) 0.88
Structure of mouse L-chain ferritin at 1.6 A resolution. Acta Crystallogr D Biol Crystallogr (2001) 0.88
The X-ray three-dimensional structure of avidin. Biomol Eng (1999) 0.88
Effects of modifications near the 2-, 3- and 4-fold symmetry axes on human ferritin renaturation. Biochem J (1997) 0.87
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype. FEBS Lett (1999) 0.87
Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood (1989) 0.87
Mechanisms of regulation of ferritin synthesis in rat liver during experimental inflammation. Exp Mol Pathol (1988) 0.87
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle. Br J Haematol (2000) 0.86
An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen. Structure (1999) 0.86
Reconstitution of manganese oxide cores in horse spleen and recombinant ferritins. J Inorg Biochem (1995) 0.86
Human ferritin H-chains can be obtained in non-assembled stable forms which have ferroxidase activity. FEBS Lett (1993) 0.86
Human serum ferritin G-peptide is recognized by anti-L ferritin subunit antibodies and concanavalin-A. Br J Haematol (1987) 0.86
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. Br J Haematol (2000) 0.85
Structural studies on recombinant human ferritins. Biochem Soc Trans (1990) 0.85
Atomic force microscopy imaging of lipid rafts of human breast cancer cells. Biochim Biophys Acta (2012) 0.85
Transient overexpression of human H- and L-ferritin chains in COS cells. Biochem J (1998) 0.85
JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia. Leukemia (2006) 0.84
Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors. Blood (1986) 0.84
Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines. Blood (1988) 0.84
Effects of recombinant human H-subunit and L-subunit ferritins on in vitro growth of human granulocyte-monocyte progenitors. Br J Haematol (1988) 0.84
Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem (1999) 0.83
Deficient ferritin immunoreactivity in tissues from niemann-pick type C patients: extension of findings to fetal tissues, H and L ferritin isoforms, but also one case of the rare Niemann-Pick C2 complementation group. Mol Genet Metab (2000) 0.83